Deniz AVCI, Nesimi BÜYÜKBABANİ, Tevfik ECDER, Gönenç KOCABAY, Serpil GÖRÇİN

Koroner anjiyografi sonrası gelişen kolesterol kristal embolisi sendromu

Kolesterol kristal embolisi sendromu, özellikle aterosklerozu olan yaşlı hastalarda görülen ve birçok organı etkileyebilen bir hastalıktır. Özgün bir tedavisi olmaması nedeniyle, erken tanı ve korunma esastır. Riskli popülasyonun ve invazif girişimlerin artışı nedeniyle, gelecekte hastalık ile daha sık karşılaşılacaktır. Bu yazıda, sıklığı gelişen invazif yöntemlere paralel olarak artan, ancak tanısı- spektrumun geniş olması nedeniyle-aynı oranda artmayan kolesterol embolizasyon sendromu, bir olgu nedeniyle tartışılmıştır.

Cholesterol crystal embolization syndrome which developed after coronary angiography

Cholesterol crystal embolization syndrome is a syndrome which is particularly seen in atherosclerotic old patients and may affect multiple organs. There is no specific treatment for this syndrome. Therefore, early diagnosis and prevention are essential. It is highly likely that this syndrome will be seen commonly in the future, because of increasing risky population and invasive procedures. Acase of cholesterol crystal embolization syndrome which was seen in association with commonly used invasive procedures, but not diagnosed at the same rate, was reported.

PDF

___

1) Dupont PJ, Lightstone L, Ckutterbuck EJ, Gaskin G. Lesson of the week: Cholesterol emboli syndrome. BMJ 2000; 321: 1065-1067.
2) Hasegawa M, Kawashima S, Shikano M, Hasegawa H, Tomita M, Murakami K, Kushimoto H, Katsumata H, Toba T, Oohashi A, Hiramitsu S, Matsunaga K. The evaluation of corticosteroid therapy in conjuction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am J Nephrol 2000; 20: 263-267.
3) Kaşıkçıoğlu HA, Çam N. Kolesterol Embolizasyon Sendromu: Sıklığı artan ancak tanı oranı artmayan bir sendrom. Türk Kardiyol Dern Arş 2002; 30: 647-651.
4) Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens 2001; 14: 831-834.
5) Rhodes JM. Cholesterol crystal embolism : an important "new" diagnosis for the general physician. Lancet 1996; 347: 1641- 1646.
6) Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi S, Zorat S, Bonardelli S, Tardanico R, Maiorca R. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant 1996; 11: 1607- 1612.
7) Scolari F, Tardanico R, Pola A, Mazzucchelli C, Maffeis R, Bonardelli S, Maiorca P, Movilli E, Sandrini S. Cholesterol crystal embolic disease in renal allografts. J Nephrol 2003; 16: 139-143.
8) Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R. Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 2000; 36: 1089-1109.
9) Smith MC, Ghose MK, Henry AR. The clinical spectrum of renal cholesterol embolization. Am J Med 1981; 71:174-180.
10) Theriault J, Agharazzi M, Dumont M, Pichette V, Ouimet D, Leblanc M. Atheroembolic renal failure requiring dialysis: potential for renal recovery, A review of 43 cases. Nephron Clin Pract. 2003; 94: 11-18.
11) Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998; 2: 1331-1332.
12) Zuccala A, Zucceli P. Arenal disease frequently found at postmortem, but rarely diagnosed in vivo. Nephrol Dial Transplant 1997; 12: 1762-1767.